Abstract: ABSTRACT BENZOHYDRAZIDES-BASED SUPRAZYMES, AND PROCESSESS THEREOF The present disclosure provides a compound of Formula (I), its stereoisomers, tautomers, polymorphs, intermediates, or pharmaceutically acceptable salts 5 thereof, Formula (I) wherein, R1 is independently selected from hydrogen, or C1-12 alkoxy, 10 wherein, C1-12 alkoxy is optionally substituted with one or more groups selected from C6-12 aryl, or C8-18 arylalkoxyaryl; wherein C6-12 aryl is optionally substituted with one or more groups selected from C1-12 alkoxy or C7-18 alkoxyaryl; R2 and Rꞌ2 are independently selected from hydrogen, hydroxy, or C1-12 alkyl; or R2 and Rꞌ2 combined together to form C6-12 aryl; 15 Rꞌ3 and Rꞌ3 are independently selected from hydrogen, hydroxy, or C1-12 alkyl; or R3 and Rꞌ3 combined together to form C6-12 aryl; and n is independently selected from 1 to 3. The present disclosure further provides a suprazyme comprising the compound of Formula (I) as disclosed herein and a first solvent. Furthermore, the present disclosure provides a lyophilized 20 suprazyme, a reconstituted suprazyme and processes thereof. In addition, the present disclosure provides a method for generating reactive oxygen species.
Description:AS ATTACHED , Claims:AS ATTACHED
| # | Name | Date |
|---|---|---|
| 1 | 202541036116-STATEMENT OF UNDERTAKING (FORM 3) [14-04-2025(online)].pdf | 2025-04-14 |
| 2 | 202541036116-REQUEST FOR EARLY PUBLICATION(FORM-9) [14-04-2025(online)].pdf | 2025-04-14 |
| 3 | 202541036116-POWER OF AUTHORITY [14-04-2025(online)].pdf | 2025-04-14 |
| 4 | 202541036116-FORM-9 [14-04-2025(online)].pdf | 2025-04-14 |
| 5 | 202541036116-FORM FOR SMALL ENTITY(FORM-28) [14-04-2025(online)].pdf | 2025-04-14 |
| 6 | 202541036116-FORM 1 [14-04-2025(online)].pdf | 2025-04-14 |
| 7 | 202541036116-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [14-04-2025(online)].pdf | 2025-04-14 |
| 8 | 202541036116-EDUCATIONAL INSTITUTION(S) [14-04-2025(online)].pdf | 2025-04-14 |
| 9 | 202541036116-DRAWINGS [14-04-2025(online)].pdf | 2025-04-14 |
| 10 | 202541036116-DECLARATION OF INVENTORSHIP (FORM 5) [14-04-2025(online)].pdf | 2025-04-14 |
| 11 | 202541036116-COMPLETE SPECIFICATION [14-04-2025(online)].pdf | 2025-04-14 |
| 12 | 202541036116-FORM 18A [15-04-2025(online)].pdf | 2025-04-15 |
| 13 | 202541036116-EVIDENCE OF ELIGIBILTY RULE 24C1f [15-04-2025(online)].pdf | 2025-04-15 |
| 14 | 202541036116-FORM-8 [16-04-2025(online)].pdf | 2025-04-16 |
| 15 | 202541036116-FER.pdf | 2025-06-02 |
| 16 | 202541036116-FORM 3 [10-07-2025(online)].pdf | 2025-07-10 |
| 17 | 202541036116-Proof of Right [25-08-2025(online)].pdf | 2025-08-25 |
| 18 | 202541036116-FER_SER_REPLY [06-10-2025(online)].pdf | 2025-10-06 |
| 19 | 202541036116-CLAIMS [06-10-2025(online)].pdf | 2025-10-06 |
| 20 | 202541036116-US(14)-HearingNotice-(HearingDate-05-12-2025).pdf | 2025-11-03 |
| 1 | 202541036116_SearchStrategyNew_E_202541036116E_02-06-2025.pdf |
| 2 | 202541036116_SearchStrategyAmended_E_2025410361162AE_21-10-2025.pdf |